STAAR Surgical Company (STAA) — Analyst outlook / Analyst consensus target is. Based on 14 analyst ratings, the consensus is bullish — 2 Buy, 11 Hold, 1 Sell.
The consensus price target is $21.95 (low: $13.00, high: $30.75), representing a downside of 10.2% from the current price $24.43.
Analysts estimate Earnings Per Share (EPS) of $0.34 and revenue of $0.33B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.41 vs est $0.34 (missed -220.6%). 2025: actual $-1.62 vs est $0.69 (missed -333.7%). Analyst accuracy: 0%.
STAA Stock — 12-Month Price Forecast
$21.95
▼ -10.15% Downside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for STAAR Surgical Company, the average price target is $21.95, with a high forecast of $30.75, and a low forecast of $13.00.
The average price target represents a -10.15% change from the last price of $24.43.
Highest Price Target
$30.75
Average Price Target
$21.95
Lowest Price Target
$13.00
STAA Analyst Ratings
Hold
Based on 14 analysts giving stock ratings to STAAR Surgical Company in the past 3 months
EPS Estimates — STAA
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.41
vs Est $0.34
▼ 182.9% off
2025
Actual –$1.62
vs Est $0.69
▼ 142.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
Revenue Estimates — STAA
75%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.314B
vs Est $0.333B
▼ 6.1% off
2025
Actual $0.239B
vs Est $0.342B
▼ 43.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
